Estrogen (E2) through its nuclear receptor alpha (ERα) and beta (ERβ), activates several pathways involved in lung carcinogenesis, including cell proliferation, tumor growth, antiapoptotic signals, angiogenesis, migration, and metastasis (25–27). This evidence concerns the gene ESR1 and neoplasm.